100 related articles for article (PubMed ID: 20160501)
1. GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells.
Shi X; Wang D; Ding K; Lu Z; Jin Y; Zhang J; Pan J
Cancer Biol Ther; 2010 Apr; 9(8):640-50. PubMed ID: 20160501
[TBL] [Abstract][Full Text] [Related]
2. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis.
Carlos JAEG; Lima K; Costa-Lotufo LV; Leitão A; Machado-Neto JA
Invest New Drugs; 2021 Aug; 39(4):1139-1149. PubMed ID: 33475938
[TBL] [Abstract][Full Text] [Related]
3. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.
Nakahara T; Kita A; Yamanaka K; Mori M; Amino N; Takeuchi M; Tominaga F; Hatakeyama S; Kinoyama I; Matsuhisa A; Kudoh M; Sasamata M
Cancer Res; 2007 Sep; 67(17):8014-21. PubMed ID: 17804712
[TBL] [Abstract][Full Text] [Related]
4. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
[TBL] [Abstract][Full Text] [Related]
5. Antisense inhibition of survivin expression as a cancer therapeutic.
Carrasco RA; Stamm NB; Marcusson E; Sandusky G; Iversen P; Patel BK
Mol Cancer Ther; 2011 Feb; 10(2):221-32. PubMed ID: 21216939
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
7. Suppression of colorectal tumor growth by regulated survivin targeting.
Li B; Fan J; Liu X; Qi R; Bo L; Gu J; Qian C; Liu X
J Mol Med (Berl); 2006 Dec; 84(12):1077-86. PubMed ID: 17077982
[TBL] [Abstract][Full Text] [Related]
8. Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.
Fang W; Che X; Li G; Wang A; Wang Y; Shi X; Hou K; Zhang X; Qu X; Liu Y
J Exp Clin Cancer Res; 2020 May; 39(1):82. PubMed ID: 32381104
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells.
Song MQ; Zhu JS; Chen JL; Wang L; Da W; Zhu L; Zhang WP
World J Gastroenterol; 2007 Mar; 13(12):1788-93. PubMed ID: 17465467
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer.
Chen XX; Xie FF; Zhu XJ; Lin F; Pan SS; Gong LH; Qiu JG; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Shi Z; Yan XJ
Oncotarget; 2015 Jun; 6(17):14926-39. PubMed ID: 25962959
[TBL] [Abstract][Full Text] [Related]
12. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Kim-Park S; Ulasov IV; Zhou F; Alvarez RD; Siegal GP; Curiel DT
Int J Oncol; 2005 Jul; 27(1):237-46. PubMed ID: 15942665
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.
Conde M; Michen S; Wiedemuth R; Klink B; Schröck E; Schackert G; Temme A
BMC Cancer; 2017 Dec; 17(1):889. PubMed ID: 29282022
[TBL] [Abstract][Full Text] [Related]
14. K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells.
Nakai R; Iida S; Takahashi T; Tsujita T; Okamoto S; Takada C; Akasaka K; Ichikawa S; Ishida H; Kusaka H; Akinaga S; Murakata C; Honda S; Nitta M; Saya H; Yamashita Y
Cancer Res; 2009 May; 69(9):3901-9. PubMed ID: 19351824
[TBL] [Abstract][Full Text] [Related]
15. Co-inhibition of Aurora A and Haspin kinases enhances survivin blockage and p53 induction for mitotic catastrophe and apoptosis in human colorectal cancer.
Lin CI; Chen ZC; Chen CH; Chang YH; Lee TC; Tang TT; Yu TW; Yang CM; Tsai MC; Huang CC; Yang TW; Lin CC; Wang RH; Chiou GY; Jong YJ; Chao JI
Biochem Pharmacol; 2022 Dec; 206():115289. PubMed ID: 36241092
[TBL] [Abstract][Full Text] [Related]
16. Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges.
Marioni G; D'Alessandro E; Bertolin A; Staffieri A
Acta Otolaryngol; 2010; 130(1):4-9. PubMed ID: 19322702
[TBL] [Abstract][Full Text] [Related]
17. EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells.
Lin X; Liu S; Luo X; Ma X; Guo L; Li L; Li Z; Tao Y; Cao Y
Int J Cancer; 2009 Mar; 124(5):1020-7. PubMed ID: 19048596
[TBL] [Abstract][Full Text] [Related]
18. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
19. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.
Zhang F; Li M; Wu X; Hu Y; Cao Y; Wang X; Xiang S; Li H; Jiang L; Tan Z; Lu W; Weng H; Shu Y; Gong W; Wang X; Zhang Y; Shi W; Dong P; Gu J; Liu Y
Drug Des Devel Ther; 2015; 9():3969-87. PubMed ID: 26309394
[TBL] [Abstract][Full Text] [Related]
20. Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNA.
Hanke M; Dubois J; Kausch I; Petkovic S; Sczakiel G
PLoS One; 2020; 15(7):e0229193. PubMed ID: 32614890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
